white/inflammation

FIELD OF THE INVENTION The invention is related to methods of diagnosing inflammatory diseases or conditions by determining levels of components of the complement pathway on the surface of white blood cells. BACKGROUND OF THE INVENTION This invention relates to the diagnosis and/or monitoring of

FIELD OF THE INVENTION The present invention relates to a process for inhibiting the adhesion between white blood cells and endothelial cells. More specifically, the present invention is a process to prevent white blood cells from attaching to the interior of blood vessels to ultimately prevent them

FIELD OF THE INVENTION The invention relates to white light endoscopy to guide the biopsy collection, and more particularly to detecting an intrinsic optical signature of early cancer lesions in Barrett's esophagus (BE) using diffuse reflectance spectroscopy, without staining or dying to enhance

FIELD OF THE INVENTION This invention pertains to therapeutic methods of preventing, and the treatment and repair of damaged cells and tissues from injuries and the resulting disease states in mammals caused by the inflammatory production of pain, erythema, itching, crusting, swelling, an

The present invention relates to a preparation containing fertilized egg and its preparation process. It also relates to its therapeutic use as regenerating agent, analgesic agent and/or anti-inflammatory agent, and its cosmetic use. It also relates to the functional food, dietary supplement,

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for treating or inhibiting the development of a disease, disorder or condition, which is associated with increased capillary permeability and white blood cell extravasation, such as brain inflammation and

BACKGROUND OF THE INVENTION The present invention is generally in the field of diagnostics for different types of inflammation, for example, whether the inflammation is due to bacterial infection or autoimmune disease. The immune system is a bodywide network of cells and organs that has evolved to

FIELD OF THE INVENTION The present invention relates to a treatment for inflammatory bowel disease (IBD). More particularly, this invention relates to the use of antibodies recognizing the integrin VLA-4 (very late antigen-4 ) in the treatment of IBD. BACKGROUND OF THE INVENTION Inflammatory bowel

FIELD OF THE INVENTION The present invention relates to a treatment for inflammatory bowel disease (IBD). More particularly, this invention relates to the use of antibodies recognizing the integrin VLA-4 (very late antigen-4) in the treatment of IBD. BACKGROUND OF THE INVENTION Inflammatory bowel

The present invention relates to an injectable solution, with anti-inflammatory effect, a process for manufacturing the same and a method for the treatment of autoimmune diseases using the said solution. It is known that an increased number of human diseases, e.g. nephrosis, rheumatoid arthritis,

FIELD OF THE INVENTION The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin. BACKGROUND OF THE

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable THE NAMES OF THE PARTIES TO A JOINT RESEARCH AGREEMENT Not Applicable INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC Not Applicable BACKGROUND OF THE INVENTION This invention is intended provide an

DESCRIPTION 1. Field of the Invention The present invention relates to a method of treatment of a pulmonary inflammatory reaction with activation of polymorphonuclear white blood cells in a human patient. The invention further relates to use of adenosine for the manufacture of a medicament for such

FIELD OF THE INVENTION The present invention provides novel methods for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of an inflammatory agent in mammalian cells comprising contacting the mammalian cells with a therapeutically effective amount of an

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention provides novel methods for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of an inflammatory agent in mammalian cells comprising contacting the mammalian cells with a